. | Gla-300 (n = 404) . | Gla-100 (n = 403) . |
---|---|---|
Age (years) | 60.1 (8.5) | 59.8 (8.7) |
Sex (male), n (%) | 217 (53.7) | 210 (52.1) |
Ethnic group, n (%) | ||
Caucasian | 371 (91.8) | 374 (92.8) |
Black | 26 (6.4) | 21 (5.2) |
Asian/Oriental | 6 (1.5) | 5 (1.2) |
Other | 1 (0.2) | 3 (0.7) |
Body weight (kg) | 106.2 (21.5) | 106.4 (20.0) |
BMI (kg/m2) | 36.6 (6.8) | 36.6 (6.1) |
Duration of diabetes (years) | 15.6 (7.2) | 16.1 (7.8) |
Duration of basal insulin treatment (years) | 6.7 (4.7) | 6.5 (4.8) |
Basal insulin dose | ||
(units/kg/day) | 0.67 (0.26) | 0.67 (0.24) |
(units/day) | 70.0 (30.4) | 70.3 (28.5) |
Mealtime insulin dose | ||
(units/kg/day) | 0.54 (0.34) | 0.54 (0.32) |
(units/day) | 57.1 (36.5) | 58.4 (37.9) |
Total insulin dose | ||
(units/kg/day) | 1.19 (0.48) | 1.20 (0.45) |
(units/day) | 126.3 (56.7) | 128.0 (56.1) |
Prior use of insulin glargine, n (%) | 373 (92.3) | 369 (91.6) |
Prior use of metformin, n (%) | 227 (56.2) | 236 (58.6) |
FPG | ||
(mmol/L) | 8.8 (2.9) | 8.9 (2.9) |
(mg/dL) | 158.3 (51.8) | 160.7 (52.8) |
HbA1c | ||
(%) | 8.15 (0.78) | 8.16 (0.77) |
(mmol/mol) | 65.6 (8.5) | 65.7 (8.4) |
. | Gla-300 (n = 404) . | Gla-100 (n = 403) . |
---|---|---|
Age (years) | 60.1 (8.5) | 59.8 (8.7) |
Sex (male), n (%) | 217 (53.7) | 210 (52.1) |
Ethnic group, n (%) | ||
Caucasian | 371 (91.8) | 374 (92.8) |
Black | 26 (6.4) | 21 (5.2) |
Asian/Oriental | 6 (1.5) | 5 (1.2) |
Other | 1 (0.2) | 3 (0.7) |
Body weight (kg) | 106.2 (21.5) | 106.4 (20.0) |
BMI (kg/m2) | 36.6 (6.8) | 36.6 (6.1) |
Duration of diabetes (years) | 15.6 (7.2) | 16.1 (7.8) |
Duration of basal insulin treatment (years) | 6.7 (4.7) | 6.5 (4.8) |
Basal insulin dose | ||
(units/kg/day) | 0.67 (0.26) | 0.67 (0.24) |
(units/day) | 70.0 (30.4) | 70.3 (28.5) |
Mealtime insulin dose | ||
(units/kg/day) | 0.54 (0.34) | 0.54 (0.32) |
(units/day) | 57.1 (36.5) | 58.4 (37.9) |
Total insulin dose | ||
(units/kg/day) | 1.19 (0.48) | 1.20 (0.45) |
(units/day) | 126.3 (56.7) | 128.0 (56.1) |
Prior use of insulin glargine, n (%) | 373 (92.3) | 369 (91.6) |
Prior use of metformin, n (%) | 227 (56.2) | 236 (58.6) |
FPG | ||
(mmol/L) | 8.8 (2.9) | 8.9 (2.9) |
(mg/dL) | 158.3 (51.8) | 160.7 (52.8) |
HbA1c | ||
(%) | 8.15 (0.78) | 8.16 (0.77) |
(mmol/mol) | 65.6 (8.5) | 65.7 (8.4) |
Data are presented as mean (SD), unless otherwise indicated.